Concord Drugs
add_icon

Concord Drugs

77.18
+3.67
(4.99%)
Market Cap
₹77.17 Cr
PE Ratio
126.74
Volume
4,959.00
Day High - Low
₹77.18 - ₹74.94
52W High-Low
₹92.52 - ₹26.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
77.17 Cr
EPS
0.34
PB Ratio
2.14
Book Value
34.42
EBITDA
4.10
Dividend Yield
0.00 %
Industry
Healthcare
ROE Growth %
-
Debt to Equity
0.54
Forecast For
Actual

Company News

View All News
Caret
neutral
Three promoters of Concord Drugs Limited - S. Koni Reddy, S. Nagi Reddy, and S Manoj Kumar Reddy - acquired additional shares through preferential allotment on 20 November 2025. The transaction increased the company's equity share capital from 1,00,00,000 to 1,31,75,000 shares, with total diluted share capital reaching 1,52,00,000 shares.
positive
Concord Drugs Limited's Board approved the allotment of 31,75,000 equity shares at Rs. 36.30 per share raising Rs. 11,52,52,500 and 20,25,000 convertible warrants aggregating Rs. 7,35,07,500. The allotments were made to promoters and public investors on preferential basis, with warrants convertible within 18 months from allotment date.
neutral
Concord Drugs Limited's Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025, showing revenue from operations of Rs 2,345.87 lakhs and net profit of Rs 30.53 lakhs for the half year period. The pharmaceutical company's results were reviewed by the Audit Committee and auditors, with earnings per share of Rs 0.31 for the reporting period.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,785.50
#1 4,28,401.26
40.65
#1 54,729.00
9.71
#1 10,980
2.89
55.66
6,294.50
1,67,099.20
67.22
9,712.00
18.67
2,191
35.10
38.25
3,794.40
1,28,419.74
59.51
11,539.40
6.99
1,911
30.46
60.08
1,490.90
1,20,428.05
22.16
28,409.50
7.12
5,291
3.71
38.84
1,250.80
1,04,393.49
#1 18.13
33,741.20
16.73
5,725
-0.38
49.30
2,055.40
93,881.32
21.56
22,909.50
13.74
3,306
#1 72.75
53.83
923.60
92,935.77
18.41
23,511.00
18.55
4,615
34.60
37.80
2,148.90
88,697.67
50.71
12,744.20
#1 20.90
2,007
-21.05
24.60
1,172.60
68,104.80
19.73
32,345.60
9.43
3,484
3.81
45.52
5,598.50
66,938.47
28.10
13,458.30
3.70
2,216
10.98
45.90
Growth Rate
Revenue Growth
0.89 %
Net Income Growth
-40.00 %
Cash Flow Change
370.89 %
ROE
-29.29 %
ROCE
5.76 %
EBITDA Margin (Avg.)
1.66 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
16
13
14
14
12
9
8
13
16
12
12
11
10
14
10
Expenses
15
12
13
12
11
8
6
12
15
11
12
9
9
13
9
EBITDA
1
1
1
1
1
2
2
1
0
1
1
1
1
1
1
Operating Profit %
4 %
8 %
9 %
11 %
8 %
16 %
21 %
5 %
2 %
7 %
7 %
13 %
10 %
7 %
11 %
Depreciation
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
1
0
0
1
1
0
1
1
1
1
1
Profit Before Tax
0
0
0
1
0
1
1
-0
-1
0
0
1
0
0
0
Tax
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
Net Profit
0
0
0
0
0
1
1
-0
-0
0
0
0
0
0
0
EPS in ₹
0.03
0.21
0.21
0.52
0.17
0.53
0.60
-0.24
-0.34
0.03
0.04
0.23
0.04
0.12
0.19

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
56
58
59
65
Fixed Assets
14
13
12
12
Current Assets
42
44
38
41
Capital Work in Progress
1
1
2
2
Investments
0
1
1
1
Other Assets
42
44
45
50
Total Liabilities
56
58
59
65
Current Liabilities
24
22
21
26
Non Current Liabilities
4
5
4
5
Total Equity
28
32
34
34
Reserve & Surplus
20
22
24
24
Share Capital
9
9
10
10

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
Investing Activities
-2
-2
-1
-2
Operating Activities
1
2
1
4
Financing Activities
2
1
0
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
44.38 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
49.00 %
52.13 %
52.13 %
52.13 %
55.41 %
55.41 %
55.41 %
55.41 %
54.39 %
54.39 %
54.39 %
54.39 %
54.39 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.90 %
50.05 %
50.05 %
50.47 %
50.65 %
50.68 %
50.67 %
50.71 %
47.60 %
47.59 %
47.54 %
44.29 %
44.27 %
44.28 %
44.30 %
45.11 %
45.11 %
43.33 %
42.57 %
44.95 %
Others
0.73 %
0.95 %
0.95 %
0.53 %
0.35 %
0.32 %
0.33 %
0.29 %
0.27 %
0.28 %
0.33 %
0.30 %
0.32 %
0.31 %
0.29 %
0.50 %
0.50 %
2.28 %
3.04 %
0.66 %
No of Share Holders
2,173
2,826
2,826
3,071
3,047
3,036
3,188
3,321
3,215
3,198
3,957
3,963
4,032
4,734
4,755
5,073
5,073
5,252
5,189
4,718

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 37.89 37.27
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 38.11 36.87
11 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Jan 2025 37.38 36.71
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 31.98 31.97
30 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Jul 2025 51.45 56.00
31 Jul 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
31 Jul 2025 55.48 56.00
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 57.12 55.84
30 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2025 68.60 65.40
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 67.01 88.15

Announcements

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Nov 25, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Nov 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 22, 2025
Board Meeting Outcome for Outcome Of Board Meeting For Allotment Of Equity Shares And Convertible WarrantsNov 20, 2025
Announcement under Regulation 30 (LODR)-AllotmentNov 20, 2025
Financial Results For Quarter Ended 30 Sep 2025Nov 13, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 13, 2025
Board Meeting Intimation for Quarterly ResultsNov 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Reg. 34 (1) Annual Report.Sep 09, 2025
Letter To ShareholdersSep 08, 2025
Annual ReportSep 08, 2025
Notice For AGMSep 08, 2025
Record Date For AGMSep 08, 2025
Book Closure For AGMSep 08, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 08, 2025
Board Meeting Outcome for Out Come Of Board MeetingSep 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Financial Results For Quarter Ending 30 June 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Board Meeting Intimation for Quarterly ResultsAug 01, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of EGMJul 31, 2025
Corrigendum To The Notice Of EGMJul 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Notice Of EGMJul 09, 2025
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJul 03, 2025
Board Meeting Outcome for Out Come Of Board MeetingJul 03, 2025
Clarification Letter Sought From BSEJul 02, 2025
Clarification sought from Concord Drugs LtdJul 02, 2025
Board Meeting Intimation for Issue Of Shares Through Preferential AllotmentJun 30, 2025
Board Meeting Outcome for Outcome Of Board MeetingJun 27, 2025
Closure of Trading WindowJun 26, 2025
Board Meeting Intimation for Considering And Approval Of Preferential IssueJun 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Financial Results For Quarter And Financial Year Ending March 31 St 2025.May 23, 2025
Board Meeting Outcome for Board Meeting Outcome For Audited Results To Consider Audited Results For Year Ending March 31St 2025May 23, 2025
Board Meeting Intimation for Consideration And Approval Of Audited ResultsMay 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Closure of Trading WindowMar 26, 2025
Board Meeting Outcome for Outcome Of Board MeetingMar 17, 2025
Board Meeting Intimation for Reschedule Of Board MeetingMar 13, 2025
Board Meeting Intimation for To Consider Fund Raising By Way Of Preferential IssueMar 04, 2025

Technical Indicators

RSI(14)
Neutral
50.27
ATR(14)
Less Volatile
4.63
STOCH(9,6)
Neutral
28.07
STOCH RSI(14)
Oversold
12.42
MACD(12,26)
Bearish
-1.21
ADX(14)
Weak Trend
17.31
UO(9)
Bearish
45.02
ROC(12)
Uptrend And Accelerating
2.91
WillR(14)
Neutral
-56.69